A patient with vCJD who showed “remarkable� improvement after a controversial
drug treatment has died after reportedly suffering liver damage. Rachel Forber
was diagnosed with the human form of mad cow disease in June. Two months later
she began a course of chlorpromazine, an antipsychotic, and quinacrine, which is
normally used against malaria. Laboratory tests suggested that both drugs can
block the formation of prions, which cause vCJD. “It’s terrible for hope to be
given and then snatched away like that. We’re right back where we started with
no cure,� says Francis Hall of Britain’s Human BSE Foundation. But authorities
including Britain’s Medical Research Council say her death will not slow
preparations for full-scale trials of the drugs on patients in the US and
Britain.
More from New Ä¢¹½Ö±²¥
Explore the latest news, articles and features
Humans
Homo erectus survived on mainland Asia 215,000 years longer than we thought
News
Technology
Quantum trick lets you share your location super securely
News
Space
Cannibal giant star caught devouring its companion in super-rare event
News
Mind
Can technology recreate the mental health benefits of psychedelic trips?
Features
Popular articles
Trending New Ä¢¹½Ö±²¥ articles